Skip to content

Company information lookup

SIRTEX MEDICAL LIMITED (SRX)

Research and commercial development of treatments for liver cancer

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
SRX 15.460 -1.53% 15.450 15.900 15.700 15.820 15.460 183,903

SIRTEX MEDICAL LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code SRX
Securities
Official Listing Date 24 August, 2000
GICS Industry Group Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign? No
Internet Address http://www.sirtex.com
Registered Office Address Level 33, 101 Miller Street, NORTH SYDNEY, NSW, AUSTRALIA, 2060
Head Office Telephone (02) 9964 8400
Head Office Fax (02) 9964 8410
Share Registry BOARDROOM PTY LIMITED
LEVEL 7, 207 KENT STREET, SYDNEY, NSW, AUSTRALIA, 2000
Share Registry Telephone (02) 9290 9600
Directors / Senior Management
Mr Richard Hill (Chairman)
Dr John Eady (Deputy Chairman, Non Exec. Director)
Mr Gilman Wong (CEO, Director)
Mr Grant Boyce (Non Exec. Director)
Mr Darren Smith (CFO)
Company Secretary Mr Darren Smith
Principal Activities Research and commercial development of treatments for liver cancer

SIRTEX MEDICAL LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
04/04/2014   Change in substantial holding from PPT 8 PDF
03/04/2014 asterix 18.2 Per Cent Dose Sales Growth for the 3rd Quarter 1 PDF
24/03/2014 asterix Sitrex and Gierbet to Collaborate on Clinical Studeis 3 PDF
27/02/2014   Change in substantial holding - hhl 5 PDF
25/02/2014   Investor Lunch Presentation 69 PDF
21/02/2014   Change in substantial holding from PPT 8 PDF
19/02/2014   Change in substantial holding from PPT 9 PDF
18/02/2014   Change in substantial holding from PPT 9 PDF
18/02/2014   Half Year Results Investor Presentation 17 PDF
18/02/2014 asterix Half Yearly Report and Accounts 21 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
17 Apr 2014 15.460 -1.53% 15.820 15.460 183,903
16 Apr 2014 15.700 2.08% 15.915 15.560 171,322
15 Apr 2014 15.380 0.07% 15.670 15.350 174,165
14 Apr 2014 15.370 -2.72% 15.920 15.230 248,032
11 Apr 2014 15.800 -1.25% 16.010 15.570 140,328

* Volume of shares shown represents only those shares traded on ASX.

SIRTEX MEDICAL LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

Code Div Amount Ex Div Date Record Date Date Payable % Franked Type Further Information
SRX 12c 04/10/2013 11/10/2013 25/10/2013 100% Final 12C FRANKED @ 30%

Exchange Traded Options

No Exchange Traded Options are available over the security SRX

Warrants & Structured Products

Warrants & Structured Products are available over the security SRX. Click here to view the current warrant issue details.

ASX CFDs

No Contracts For Differences are available over the security SRX